vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.

COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $49.9M, roughly 1.9× MARAVAI LIFESCIENCES HOLDINGS, INC.). COMSCORE, INC. runs the higher net margin — 3.2% vs -71.6%, a 74.8% gap on every dollar of revenue. On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -11.8%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-24.9M). Over the past eight quarters, COMSCORE, INC.'s revenue compounded faster (3.8% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.

MRVI vs SCOR — Head-to-Head

Bigger by revenue
SCOR
SCOR
1.9× larger
SCOR
$93.5M
$49.9M
MRVI
Growing faster (revenue YoY)
SCOR
SCOR
+10.3% gap
SCOR
-1.5%
-11.8%
MRVI
Higher net margin
SCOR
SCOR
74.8% more per $
SCOR
3.2%
-71.6%
MRVI
More free cash flow
SCOR
SCOR
$27.8M more FCF
SCOR
$2.9M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
SCOR
SCOR
Annualised
SCOR
3.8%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
SCOR
SCOR
Revenue
$49.9M
$93.5M
Net Profit
$-35.7M
$3.0M
Gross Margin
25.8%
41.0%
Operating Margin
-117.9%
7.0%
Net Margin
-71.6%
3.2%
Revenue YoY
-11.8%
-1.5%
Net Profit YoY
-37.7%
-3.7%
EPS (diluted)
$-0.24
$9.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
SCOR
SCOR
Q4 25
$49.9M
$93.5M
Q3 25
$41.6M
$88.9M
Q2 25
$47.4M
$89.4M
Q1 25
$46.9M
$85.7M
Q4 24
$56.6M
$94.9M
Q3 24
$69.0M
$88.5M
Q2 24
$69.4M
$85.8M
Q1 24
$64.2M
$86.8M
Net Profit
MRVI
MRVI
SCOR
SCOR
Q4 25
$-35.7M
$3.0M
Q3 25
$-25.6M
$453.0K
Q2 25
$-39.6M
$-9.5M
Q1 25
$-29.9M
$-4.0M
Q4 24
$-25.9M
$3.1M
Q3 24
$-97.1M
$-60.6M
Q2 24
$-9.8M
$-1.7M
Q1 24
$-12.1M
$-1.1M
Gross Margin
MRVI
MRVI
SCOR
SCOR
Q4 25
25.8%
41.0%
Q3 25
13.6%
40.6%
Q2 25
16.4%
40.6%
Q1 25
16.5%
39.6%
Q4 24
34.3%
42.4%
Q3 24
46.7%
41.2%
Q2 24
44.4%
39.5%
Q1 24
40.3%
42.3%
Operating Margin
MRVI
MRVI
SCOR
SCOR
Q4 25
-117.9%
7.0%
Q3 25
-98.6%
1.9%
Q2 25
-139.8%
-1.9%
Q1 25
-104.9%
-2.4%
Q4 24
-66.7%
4.1%
Q3 24
-239.9%
-67.4%
Q2 24
-19.4%
-2.2%
Q1 24
-29.4%
-2.2%
Net Margin
MRVI
MRVI
SCOR
SCOR
Q4 25
-71.6%
3.2%
Q3 25
-61.4%
0.5%
Q2 25
-83.5%
-10.6%
Q1 25
-63.9%
-4.7%
Q4 24
-45.8%
3.3%
Q3 24
-140.6%
-68.5%
Q2 24
-14.1%
-2.0%
Q1 24
-18.8%
-1.2%
EPS (diluted)
MRVI
MRVI
SCOR
SCOR
Q4 25
$-0.24
$9.50
Q3 25
$-0.18
$-0.86
Q2 25
$-0.27
$-2.73
Q1 25
$-0.21
$-1.66
Q4 24
$-0.21
$-0.47
Q3 24
$-0.68
$-12.79
Q2 24
$-0.07
$-1.19
Q1 24
$-0.09
$-1.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
SCOR
SCOR
Cash + ST InvestmentsLiquidity on hand
$216.9M
$23.6M
Total DebtLower is stronger
$291.8M
$41.5M
Stockholders' EquityBook value
$212.4M
$111.4M
Total Assets
$770.6M
$407.7M
Debt / EquityLower = less leverage
1.37×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
SCOR
SCOR
Q4 25
$216.9M
$23.6M
Q3 25
$243.6M
$26.7M
Q2 25
$269.9M
$26.0M
Q1 25
$285.1M
$31.0M
Q4 24
$322.4M
$29.9M
Q3 24
$578.2M
$20.0M
Q2 24
$573.2M
$14.7M
Q1 24
$561.7M
$18.7M
Total Debt
MRVI
MRVI
SCOR
SCOR
Q4 25
$291.8M
$41.5M
Q3 25
$292.8M
$41.4M
Q2 25
$293.9M
$41.3M
Q1 25
$294.9M
$41.3M
Q4 24
$295.9M
$41.2M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
SCOR
SCOR
Q4 25
$212.4M
$111.4M
Q3 25
$245.4M
$-26.3M
Q2 25
$265.9M
$-21.7M
Q1 25
$300.6M
$-13.5M
Q4 24
$325.3M
$-8.3M
Q3 24
$344.9M
$-2.7M
Q2 24
$434.7M
$45.8M
Q1 24
$410.7M
$51.4M
Total Assets
MRVI
MRVI
SCOR
SCOR
Q4 25
$770.6M
$407.7M
Q3 25
$849.2M
$406.9M
Q2 25
$897.0M
$415.9M
Q1 25
$959.8M
$421.5M
Q4 24
$1.0B
$430.2M
Q3 24
$1.3B
$412.5M
Q2 24
$1.4B
$474.1M
Q1 24
$1.4B
$477.7M
Debt / Equity
MRVI
MRVI
SCOR
SCOR
Q4 25
1.37×
0.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
SCOR
SCOR
Operating Cash FlowLast quarter
$-22.8M
$3.2M
Free Cash FlowOCF − Capex
$-24.9M
$2.9M
FCF MarginFCF / Revenue
-49.9%
3.1%
Capex IntensityCapex / Revenue
4.2%
0.3%
Cash ConversionOCF / Net Profit
1.07×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$21.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
SCOR
SCOR
Q4 25
$-22.8M
$3.2M
Q3 25
$-15.2M
$9.5M
Q2 25
$-10.3M
$932.0K
Q1 25
$-9.4M
$9.1M
Q4 24
$-14.6M
$-10.0M
Q3 24
$13.1M
$12.5M
Q2 24
$17.4M
$8.7M
Q1 24
$-8.5M
$6.9M
Free Cash Flow
MRVI
MRVI
SCOR
SCOR
Q4 25
$-24.9M
$2.9M
Q3 25
$-18.1M
$9.4M
Q2 25
$-13.1M
$787.0K
Q1 25
$-14.6M
$8.7M
Q4 24
$-20.5M
$-10.3M
Q3 24
$4.5M
$12.4M
Q2 24
$7.9M
$8.5M
Q1 24
$-14.1M
$6.6M
FCF Margin
MRVI
MRVI
SCOR
SCOR
Q4 25
-49.9%
3.1%
Q3 25
-43.4%
10.5%
Q2 25
-27.7%
0.9%
Q1 25
-31.2%
10.1%
Q4 24
-36.2%
-10.8%
Q3 24
6.6%
14.0%
Q2 24
11.4%
10.0%
Q1 24
-22.0%
7.6%
Capex Intensity
MRVI
MRVI
SCOR
SCOR
Q4 25
4.2%
0.3%
Q3 25
7.0%
0.1%
Q2 25
6.1%
0.2%
Q1 25
11.2%
0.4%
Q4 24
10.3%
0.2%
Q3 24
12.4%
0.1%
Q2 24
13.8%
0.2%
Q1 24
8.8%
0.3%
Cash Conversion
MRVI
MRVI
SCOR
SCOR
Q4 25
1.07×
Q3 25
20.96×
Q2 25
Q1 25
Q4 24
-3.19×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

SCOR
SCOR

Transferred Over Time$77.1M83%
Research Insight Solutions$14.6M16%
Related Party$2.5M3%

Related Comparisons